In a press release, researchers say that aspirin can bring down the risk of a nonfatal heart attack or stroke by as much as 23 percent. This benefit has led to nearly 20 million men and women taking a low dose of aspirin for controlling their heart disease.
"Historically, studies have shown that aspirin therapy is less effective in women than in men, but it has remained unclear how much less effective and whether this affects patient outcomes," says study leader Michael Dorsch in a statement.
"I was surprised by how big of a difference it was for females. This is another piece of information that affirms we need more studies in women," adds Dorsch.
The study 'Aspirin Resistance in Patients with Stable Coronary Artery Disease' was published in the Annals of Pharmacotherapy.
